人才招聘
加入和铂，共同书写下一代抗体药物的未来。
1. Lead cross-functional teams to define program objectives, develop integrated development strategies, and build comprehensive project plans. Oversee end-to-end program development to ensure execution.
2. Monitor project deliverables, timelines, milestones and resource utilization against approved plans to ensure full alignment with program targets. Support resource prioritization and allocation and maintain accurate program data for internal systems and senior management reporting.
3. Organize regular and ad-hoc program meetings, and lead cross-functional task forces as needed. Align internal and external stakeholders on project progress, strategy updates and issue resolution. Draft meeting minutes, facilitate cross-team collaboration and drive innovative problem-solving to streamline project delivery.
4. Proactively identify program bottlenecks, potential risks and roadblocks, and analyze core program challenges. Develop contingency plans, deliver actionable solutions and strategic guidance, and optimize workflows to accelerate high-quality delivery across all workstreams.
1. A master’s degree in life-science with minimum 5-8 years relevant experience in pharmaceutical/biotech environment; experience in clinical development and/or portfolio management.
2. 3-5 years of clinical portfolio management or clinical operation experience is a plus.
3. Excellent interpersonal skills and the ability to collaborate with internal and external contacts to ensure project success.
4. Excellent project management skills (workplan/critical path, risk/issue management, governance coordination, stakeholder management).
5. Strong cross-functional leadership and influence; effective negotiation and conflict management.
6. Demonstrated writing, communication and presentation skills in both Chinese and English.
The Portfolio Management Senior Manager/Associate Director will help Line manager for effectively driving cross-functional project teams and continuously optimizing R&D portfolio to expediate the delivery of innovative medical products to address unmet medical needs of our patients globally.
1. Oversee end-to-end project management for drug programs spanning early-stage research through IND submission/clinical phase I stage. Develop detailed project management plans across key pharmaceutical development phases including early discovery, CMC, preclinical studies, IND filing and technology transfer. Monitor and govern the full drug development lifecycle to drive on-time and complete project delivery.
2. Formulate tailored project management strategies aligned with individual program characteristics. Coordinate cross-functional resources to accelerate progress across business functions; conduct end-to-end oversight of schedule, quality and cost throughout preclinical development to clinical manufacturing. Deliver all milestones and overall program targets as scheduled.
3. Collaborate with Early Discovery, Preclinical, CMC, BD and other internal departments to enable seamless cross-functional alignment and effective resource integration for project deliverables.
4. Schedule regular project governance meetings, align cross-functional teams to identify and mitigate program bottlenecks. Conduct risk forecasting and full lifecycle risk management, and provide actionable mitigation plans and resolutions to the project team.
5. Monitor ongoing program execution; escalate technical roadblocks to relevant technical leads for timely resolution, and revise project plans through cross-stakeholder alignment. Secure consensus on required deliverables for each R&D phase, and track continuous program progress to guarantee on-time delivery.
6. Lead the development, review and progress tracking of integrated research protocols, project timelines and budgets for all internal programs within the company’s quality system. Organize routine cross-functional progress updates, milestone gate reviews and change control reviews. Drive cross-departmental alignment and synergy across all technical platforms.
7. Serve as the primary liaison with external collaboration partners. Develop joint project plans, align internal and external resources, and coordinate internal functional teams to execute external partnership programs, while enforcing compliance with agreed delivery timelines and quality standards.
1. At least a master’s degree in life-science field preferred with at least 8 years of drug R&D experience in a pharmaceutical or biotech company.
2. Solid understanding of cross-functional drug R&D processes with at least 5 years in a project management role with a proven track record.
3. Excellent interpersonal skills and the ability to collaborate with internal and external contacts to ensure project success.
4. Demonstrated writing, communication and presentation skills in both Chinese and English.
5. Strong strategic thinking, problem-solving, self-management and organizational skills, ability to influence others without direct authority.
Harbour BioMed is seeking a Senior Manager/Associate Director of Strategy and Competitive Intelligence to shape and sharpen the strategic direction of our growing pipeline. Sitting at the intersection of science, strategy, and business development, you will translate complex global intelligence into clear, actionable insights that inform leadership decisions on portfolio prioritization, asset positioning, and deal-making across our core therapeutic areas (immuno-oncology, autoimmune diseases) and key modalities (bispecific antibodies, ADCs, and our proprietary HCAb platform).
• Portfolio Strategy & Prioritization. Develop and maintain Harbour's portfolio strategy. Partner with TA leaders, clinicians, and technology heads to identify high-potential opportunities. Lead asset prioritization (including methodology design) and build governance mechanisms for managing the portfolio in a dynamic competitive landscape.
• Competitive Intelligence & Landscaping. Lead systematic competitive intelligence (CI) activities revolving around our core TA and modality focus. Build, maintain, and refresh competitive landscapes for top-priority projects. Continuously track strategic deals (licensing, M&A, partnerships) across the global biopharma industry, with rigorous source triangulation and clear insight generation.
• Intelligence Sourcing. Synthesize intelligence from a broad range of sources: commercial databases (Cortellis/ Evaluate/ Biomedtracker), major medical and BD conferences (ASCO/ AACR/ JPM ), industry trade publications (Endpoints/ BioCentury/ STAT), and press release platforms etc. Translate findings into executive-ready briefings, landscape reports, and strategic recommendations.
• Governance & Decision Support. Implement governance frameworks and decision-support mechanisms across Strategy, R&D, BD, and Commercial functions to ensure portfolio and strategic decisions are evidence-based, timely, and aligned to Harbour's long-term vision.
• Executive Communication. Deliver CEO-grade outputs, concise memos, executive presentations, and deep-dive strategic reports tailored to senior leadership and cross-functional stakeholders.
• 8+ years of relevant experience in TA Strategy, Portfolio Management, Business Development, New Product Planning, Competitive Intelligence, or top-tier management consulting (life sciences focus).
• Solid understanding of the end-to-end drug discovery and development cycle, with familiarity spanning early discovery through mid- to late-stage clinical development.
• Strong project management skills and demonstrated experience working with senior management in matrix organizations, with strong cross-functional collaboration across discovery, clinical, regulatory affairs, and BD teams.
• Hands-on proficiency with mainstream intelligence and clinical trial databases.
• Excellent written and verbal communication in both English and Chinese; CEO-memo-style writing experience is highly valued.
• Advanced degree (Ph.D., M.D., M.S., or equivalent) in life sciences, medicine, pharmacology, or a related field.
• Prior experience in Harbour's core therapeutic areas: immuno-oncology, autoimmune and inflammatory diseases.
• Direct experience with our key modalities: bispecific antibodies (BsAb), antibody-drug conjugates (ADC), and T-cell engagers (TCE).
• Familiarity with various industry intelligence sources and global regulatory agency & laws.
• Prior experience supporting executive-level BD evaluations, strategic landscape reports, or portfolio governance processes at MNC or top Biotech/biopharma.
